India Reviewing 700 Serious Post-vaccine Adverse Events
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
India is reviewing around 700 'severe and serious' adverse events reported from across the country after Covid vaccination. This is in the light of global concerns over the rare or unusual type of blood clots after receiving the AstraZeneca-Oxford University vaccine.

The official said the review is significant as globally regulators are waiting for India’s data because of the sheer number of doses of Covid vaccine administered here. “Besides, we also have a large-scale AEFI monitoring and assessment mechanism already in place for the universal child immunization programme,” he added.

On April 7, the European Medicines Agency (EMA) confirmed that the cases of blood clots with low blood platelets were associated with the administration of the AstraZeneca vaccine, but should still be listed as very rare side effects. The World Health Organisation also said that a causal link between the AstraZeneca vaccine and the rare occurrence of blood clots with low platelets is considered plausible but not confirmed.

In an interim statement, WHO’s Global Advisory Committee on Vaccine Safety said that the events under assessment are very rare, with low numbers reported among the almost 200 million individuals who have received the AstraZeneca vaccine around the world. However, specialized studies are needed to fully understand the potential link.

Dr. T●●●●z H●●●●●●i and 5 others like this6 shares